Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA  AT study.

CONCLUSION: In this real-world study, ranolazine was shown to be effective, safe and well tolerable. Symptoms of AP were improved, as illustrated by the reduced number of angina attacks, reduced rate of nitrate use, reduced CCS scores and improved QoL. PMID: 30963332 [PubMed - as supplied by publisher]
Source: Wiener Klinische Wochenschrift - Category: General Medicine Authors: Tags: Wien Klin Wochenschr Source Type: research